HUP0303610A3 - Remedies for vesical stimulation in association with prostatauxe - Google Patents

Remedies for vesical stimulation in association with prostatauxe

Info

Publication number
HUP0303610A3
HUP0303610A3 HU0303610A HUP0303610A HUP0303610A3 HU P0303610 A3 HUP0303610 A3 HU P0303610A3 HU 0303610 A HU0303610 A HU 0303610A HU P0303610 A HUP0303610 A HU P0303610A HU P0303610 A3 HUP0303610 A3 HU P0303610A3
Authority
HU
Hungary
Prior art keywords
prostatauxe
vesical
remedies
stimulation
association
Prior art date
Application number
HU0303610A
Other languages
English (en)
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of HUP0303610A2 publication Critical patent/HUP0303610A2/hu
Publication of HUP0303610A3 publication Critical patent/HUP0303610A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HU0303610A 2001-03-30 2002-03-29 Remedies for vesical stimulation in association with prostatauxe HUP0303610A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001099799 2001-03-30
PCT/JP2002/003169 WO2002078712A1 (fr) 2001-03-30 2002-03-29 Remedes de stimulation vesicale en association avec une hypertrophie de la prostate

Publications (2)

Publication Number Publication Date
HUP0303610A2 HUP0303610A2 (hu) 2004-03-01
HUP0303610A3 true HUP0303610A3 (en) 2005-02-28

Family

ID=18953302

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303610A HUP0303610A3 (en) 2001-03-30 2002-03-29 Remedies for vesical stimulation in association with prostatauxe

Country Status (13)

Country Link
US (1) US7354949B2 (hu)
EP (1) EP1380299A4 (hu)
JP (1) JP4104986B2 (hu)
KR (1) KR20040007477A (hu)
CN (1) CN1230178C (hu)
BR (1) BR0208416A (hu)
CA (1) CA2442472A1 (hu)
EA (1) EA006448B1 (hu)
HK (1) HK1064616A1 (hu)
HU (1) HUP0303610A3 (hu)
MX (1) MXPA03008815A (hu)
NO (1) NO20034357L (hu)
WO (1) WO2002078712A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087131A1 (ja) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. 鎮咳剤
TW200501938A (en) * 2003-06-27 2005-01-16 Kyowa Hakko Kogyo Kk A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder
CA2532806A1 (en) * 2003-07-16 2005-01-27 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
CA2532805A1 (en) * 2003-07-16 2005-01-27 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical composition
TW200522943A (en) * 2003-12-11 2005-07-16 Kyowa Hakko Kogyo Kk Fine crystallites and a pharmaceutical composition comprising them
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU700386B2 (en) * 1995-10-16 1999-01-07 Kyowa Hakko Kogyo Co. Ltd. Triciclic compounds
EA002322B1 (ru) * 1997-04-15 2002-04-25 Киова Хакко Когио Ко., Лтд. Трициклические соединения

Also Published As

Publication number Publication date
US7354949B2 (en) 2008-04-08
WO2002078712A1 (fr) 2002-10-10
KR20040007477A (ko) 2004-01-24
HUP0303610A2 (hu) 2004-03-01
JP4104986B2 (ja) 2008-06-18
HK1064616A1 (en) 2005-02-04
EA200301078A1 (ru) 2004-02-26
BR0208416A (pt) 2004-03-02
US20040110784A1 (en) 2004-06-10
NO20034357L (no) 2003-11-24
JPWO2002078712A1 (ja) 2004-07-22
EP1380299A4 (en) 2009-05-06
CN1230178C (zh) 2005-12-07
EA006448B1 (ru) 2005-12-29
NO20034357D0 (no) 2003-09-29
EP1380299A1 (en) 2004-01-14
CA2442472A1 (en) 2002-10-10
MXPA03008815A (es) 2004-02-17
CN1499974A (zh) 2004-05-26

Similar Documents

Publication Publication Date Title
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
EP1425066A4 (en) Defibrillators
GB0206033D0 (en) Compounds useful in therapy
GB2406928B (en) Facilitating and authenticating transactions
EP1463438A4 (en) ENDOMURAL THERAPY
GB0126879D0 (en) Combination therapy
GB0218526D0 (en) Combination therapy
EP1427478A4 (en) DEFIBRILLATORS
HK1064616A1 (en) Remedies for vesical stimulation in association with prostatauxe
GB0108485D0 (en) Combination therapy
GB0101933D0 (en) Therapy
SG110107A1 (en) Compound and use in treatment
GB0122746D0 (en) Defibrillator
HUP0303609A3 (en) Remedies for vesical hyperesthesia
GB0329693D0 (en) Compounds useful in therapy
IL147696A0 (en) Combination therapy
AU2002244945A1 (en) Remedies for visical stimulation in association with prostatauxe
GB0312340D0 (en) Improved game and aricle for use with the game
GB0323693D0 (en) Facilitating and authenticating transactions
EP1386919A4 (en) REMEDIES
GB0303289D0 (en) Combination therapy
AU2425P (en) CONCA D'OR Lilium hybrid
GB0124029D0 (en) Combination therapy
GB0218525D0 (en) Combination therapy
GB0218388D0 (en) Combination therapy